BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Boldrini L, Ursino S, Gisfredi S, Faviana P, Donati V, Camacci T, Lucchi M, Mussi A, Basolo F, Pingitore R, Fontanini G. Expression and mutational status of c-kit in small-cell lung cancer: prognostic relevance. Clin Cancer Res 2004;10:4101-8. [PMID: 15217946 DOI: 10.1158/1078-0432.CCR-03-0664] [Cited by in Crossref: 58] [Cited by in F6Publishing: 16] [Article Influence: 3.4] [Reference Citation Analysis]
Number Citing Articles
1 Terada T. Primary esophageal small cell carcinoma with brain metastasis and with CD56, KIT, and PDGFRA expressions. Pathol Oncol Res. 2012;18:1091-1093. [PMID: 21626441 DOI: 10.1007/s12253-011-9374-y] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
2 Patel JN, Ersek JL, Kim ES. Lung cancer biomarkers, targeted therapies and clinical assays. Transl Lung Cancer Res 2015;4:503-14. [PMID: 26629419 DOI: 10.3978/j.issn.2218-6751.2015.06.02] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
3 Shih AJ, Telesco SE, Radhakrishnan R. Analysis of Somatic Mutations in Cancer: Molecular Mechanisms of Activation in the ErbB Family of Receptor Tyrosine Kinases. Cancers (Basel) 2011;3:1195-231. [PMID: 21701703 DOI: 10.3390/cancers3011195] [Cited by in Crossref: 15] [Cited by in F6Publishing: 14] [Article Influence: 1.7] [Reference Citation Analysis]
4 Cheng Y, Li H, Ma L, Zhang S, Yan S, Zhu J, Wang S, Zhang R, Niu K, Liu Y. Detection of c-kit mutational status in small-cell lung cancer in a Chinese cohort. Thorac Cancer 2014;5:225-31. [PMID: 26767005 DOI: 10.1111/1759-7714.12082] [Reference Citation Analysis]
5 Yokouchi H, Nishihara H, Harada T, Ishida T, Yamazaki S, Kikuchi H, Oizumi S, Uramoto H, Tanaka F, Harada M, Akie K, Sugaya F, Fujita Y, Takamura K, Kojima T, Higuchi M, Honjo O, Minami Y, Watanabe N, Goto A, Suzuki H, Dosaka-Akita H, Isobe H, Nishimura M, Munakata M. Immunohistochemical profiling of receptor tyrosine kinases, MED12, and TGF-βRII of surgically resected small cell lung cancer, and the potential of c-kit as a prognostic marker. Oncotarget 2017;8:39711-26. [PMID: 28055980 DOI: 10.18632/oncotarget.14410] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
6 Terada T. Esophageal small cell carcinoma without neuroendocrine features but with KIT and PDGFRA expression: KIT as a useful marker of this type of tumor. J Gastrointest Cancer 2014;45 Suppl 1:132-5. [PMID: 24604264 DOI: 10.1007/s12029-014-9595-x] [Cited by in Crossref: 1] [Article Influence: 0.1] [Reference Citation Analysis]
7 Lu HY, Zhang G, Cheng QY, Chen B, Cai JF, Wang XJ, Zhang YP, Wang Z, Lu ZY, Xie FJ, Mao WM. Expression and mutation of the c-kit gene and correlation with prognosis of small cell lung cancer. Oncol Lett 2012;4:89-93. [PMID: 22807968 DOI: 10.3892/ol.2012.679] [Cited by in Crossref: 18] [Cited by in F6Publishing: 20] [Article Influence: 1.8] [Reference Citation Analysis]
8 Xiao H, Wang J, Liu Y, Li L. Relative influence of c-Kit expression and epidermal growth factor receptor gene amplification on survival in patients with non-small cell lung cancer. Oncol Lett 2014;8:582-8. [PMID: 25013472 DOI: 10.3892/ol.2014.2173] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
9 Terada T. Primary small cell carcinoma of the pleura: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2010;27:1119-22. [PMID: 19859843 DOI: 10.1007/s12032-009-9345-2] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.5] [Reference Citation Analysis]
10 Terada T, Maruo H. Esophageal combined carcinomas: Immunohoistochemical and molecular genetic studies. World J Gastroenterol 2012; 18(13): 1545-1551 [PMID: 22509088 DOI: 10.3748/wjg.v18.i13.1545] [Cited by in CrossRef: 9] [Cited by in F6Publishing: 10] [Article Influence: 0.9] [Reference Citation Analysis]
11 Lu HY, Wang XJ, Mao WM. Targeted therapies in small cell lung cancer. Oncol Lett 2013;5:3-11. [PMID: 23255884 DOI: 10.3892/ol.2012.791] [Cited by in Crossref: 1] [Cited by in F6Publishing: 15] [Article Influence: 0.1] [Reference Citation Analysis]
12 Balachandran VP, Dematteo RP. Targeted therapy for cancer: the gastrointestinal stromal tumor model. Surg Oncol Clin N Am 2013;22:805-21. [PMID: 24012400 DOI: 10.1016/j.soc.2013.06.001] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
13 Santarpia M, Daffinà MG, Karachaliou N, González-Cao M, Lazzari C, Altavilla G, Rosell R. Targeted drugs in small-cell lung cancer. Transl Lung Cancer Res 2016;5:51-70. [PMID: 26958493 DOI: 10.3978/j.issn.2218-6751.2016.01.12] [Cited by in F6Publishing: 17] [Reference Citation Analysis]
14 Terada T. Primary small cell carcinoma of the mediastinum: a case report with immunohistochemical and molecular genetic analyses of KIT and PDGFRA genes. Med Oncol 2009;26:247-50. [PMID: 18989797 DOI: 10.1007/s12032-008-9116-5] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 1.0] [Reference Citation Analysis]
15 Yan F, Shen N, Pang J, Zhao N, Deng B, Li B, Yang Y, Yang P, Molina JR, Liu S. A regulatory circuit composed of DNA methyltransferases and receptor tyrosine kinases controls lung cancer cell aggressiveness. Oncogene 2017;36:6919-28. [PMID: 28869603 DOI: 10.1038/onc.2017.305] [Cited by in Crossref: 16] [Cited by in F6Publishing: 16] [Article Influence: 3.2] [Reference Citation Analysis]
16 Board RE, Thatcher N, Lorigan P. Novel therapies for the treatment of small-cell lung cancer: a time for cautious optimism? Drugs 2006;66:1919-31. [PMID: 17100404 DOI: 10.2165/00003495-200666150-00003] [Cited by in Crossref: 10] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
17 Yan F, Shen N, Pang J, Molina JR, Yang P, Liu S. The DNA Methyltransferase DNMT1 and Tyrosine-Protein Kinase KIT Cooperatively Promote Resistance to 5-Aza-2'-deoxycytidine (Decitabine) and Midostaurin (PKC412) in Lung Cancer Cells. J Biol Chem 2015;290:18480-94. [PMID: 26085088 DOI: 10.1074/jbc.M114.633693] [Cited by in Crossref: 21] [Cited by in F6Publishing: 12] [Article Influence: 3.0] [Reference Citation Analysis]